Gregory Eschenauer - Concepedia

Author

Gregory Eschenauer

Also Known As

Derek Eisnor, G. A. Eschenauer, G. Eschenauer, G.A. Eschenauer, Greg Eschenauer, Gregory A Eschenauer, Gregory A. Eschenauer, Gregory Eschenauer

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University of Michigan Michigan Medicine University of Pittsburgh Medical Center University of Pittsburgh Cleveland Clinic

About

Gregory Eschenauer is an author at University of Michigan specializing in medicine, infection control, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	378
2	Health Sciences	2	2	131
3	Public Health	2	2	47
4	Epidemiology	2	2	91
5	Nursing	1	1	20

Gregory Eschenauer

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19 Emily C. Somers, Gregory Eschenauer, Jonathan P. Troost, Clinical Infectious Diseases	2020	495
Comparison of echinocandin antifungals Gregory Eschenauer, Daryl D. DePestel, Peggy L. Carver Therapeutics and Clinical Risk Management	2007	187
Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients Ryan K. Shields, Cornelius J. Clancy, Louise M. Gillis, PLoS ONE	2012	143
Risk Factors and Outcomes Associated With Treatment of Asymptomatic Bacteriuria in Hospitalized Patients Lindsay A Petty, Valerie M. Vaughn, Scott A. Flanders, JAMA Internal Medicine	2019	142
Tocilizumab for treatment of mechanically ventilated patients with COVID-19 Emily C. Somers, Gregory Eschenauer, Jonathan P. Troost,	2020	126
Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes May Nguyen, Gregory Eschenauer, Monique Bryan, Diagnostic Microbiology and Infectious Disease Antimicrobial SusceptibilityHealth SciencesAntibioticsMicrobiologic OutcomesMedicine	2010	103
Targeted Versus Universal Antifungal Prophylaxis Among Liver Transplant Recipients Gregory Eschenauer, E.J. Kwak, Abhinav Humar, American Journal of Transplantation	2014	81
Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method Ana Espinel‐Ingroff, Maximiliano Álvarez-Fernández, Peggy L. Carver, Antimicrobial Agents and Chemotherapy Diagnostic MycologyCandida SppClinical MycologyBacterial PathogensSyo Mic Data	2015	64
Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates Gregory Eschenauer, M. Hong Nguyen, Shmuel Shoham, Antimicrobial Agents and Chemotherapy Antifungal AgentPerform Susceptibility TestingCaspofungin MicsReal-world ExperienceBloodstream Isolates	2014	60
Pharmacology and therapeutic uses of theanine Gregory Eschenauer, Burgunda V. Sweet American Journal of Health-System Pharmacy Molecular PharmacologyMedicinal ChemistryTranslational PharmacologyPharmaceutical SciencePharmacological Study	2005	59

Page 1